in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma Sector to Consolidate, Focus on R&D
10:23 AM MDT | September 8, 2008 | Deepti Ramesh
The Chinese pharmaceutical market is expected to become the fifth-largest pharmaceutical market by 2010, compared with ninth currently, analysts say. The industry is also going through a transitional phase, with increased consolidation and more companies getting involved in R&D, analysts add. China’s pharma market was worth $22 billion in 2007, Frost & Sullivan (Kolkata, India) says. The market is highly fragmented with more than 30,000 manufacturers, of which more than 90% are small and medium-size enterprises, Frost & Sullivan says. As a...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee